Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal Infection  by Guo, Xiaohuan et al.
Immunity
ArticleInduction of Innate Lymphoid Cell-Derived
Interleukin-22 by the Transcription Factor STAT3
Mediates Protection against Intestinal Infection
Xiaohuan Guo,1 Ju Qiu,2 Tony Tu,1 Xuanming Yang,1 Liufu Deng,1 Robert A. Anders,3 Liang Zhou,2,* and Yang-Xin Fu1,*
1Department of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA
2Department of Pathology and Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago,
IL 60611, USA
3Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
*Correspondence: l-zhou@northwestern.edu (L.Z.), yfu@uchicago.edu (Y.-X.F.)
http://dx.doi.org/10.1016/j.immuni.2013.10.021SUMMARY
Inhibitors of the transcription factor STAT3 target
STAT3-dependent tumorigenesis but patients often
develop diarrhea from unknown mechanisms.
Here we showed that STAT3 deficiency increased
morbidity and mortality after Citrobacter rodentium
infection with decreased secretion of cytokines
including IL-17 and IL-22 associated with the tran-
scription factor RORgt. Administration of the cyto-
kine IL-22 was sufficient to rescue STAT3-deficient
mice from lethal infection. Although STAT3 was
required for IL-22 production in both innate and
adaptive arms, by using conditional gene-deficient
mice, we observed that STAT3 expression in RORgt+
innate lymphoid cells (ILC3s), but not T cells, was
essential for the protection. However, STAT3 was
required for RORgt expression in T helper cells, but
not in ILC3s. Activated STAT3 could directly bind
to the Il22 locus. Thus, cancer therapies that utilize
STAT3 inhibitors increase the risk for pathogen-
mediated diarrhea through direct suppression of
IL-22 from gut ILCs.
INTRODUCTION
Signal transducer and activator of transcription 3 (STAT3) is
a transcription factor that regulates many genes involved in
apoptosis, proliferation, migration, and survival in different cell
types. STAT3 signaling is constitutively active in many types of
tumor cells and tumor-associated immune cells during tumori-
genesis, and this dysregulation promotes tumor growth and
suppresses antitumor immune responses (Yu et al., 2007).
Thus, STAT3 inhibitors have been explored in clinical trials for
different cancer patients (Page et al., 2011). Sunitinib, an oral
multitargeted tyrosine kinase inhibitor used for the treatment of
several types of cancers including gastrointestinal tumors, also
suppresses STAT3 activity in host immune cells (Xin et al.,
2009). However, nearly half of the patients develop diarrhea
after Sunitinib treatment with unclear pathogenesis (Schwandtet al., 2009). Mutations of STAT3 have been shown to be related
to hyper-immunoglobulin E syndrome patients with recurrent
mucosal infections (Minegishi et al., 2007). Therefore, STAT3-
related diarrhea could be linked with increased susceptibility to
mucosal infections such as intestinal infections.
Citrobacter rodentium is a natural mouse extracellular enteric
pathogen that mimics human enterohaemorrhagic E. coli and
enteropathogenic E. coli, which are major causes of diarrheal
disease worldwide that result in hundreds of thousands of
deaths each year. Clearance of C. rodentium requires both the
innate and adaptive immune responses (Bry and Brenner,
2004;Maaser et al., 2004). Both RORgt+ group 3 innate lymphoid
cells (ILC3s) and T helper (Th17, Th22) cells are important for the
host to control C. rodentium infection (Basu et al., 2012; Ivanov
et al., 2009; Qiu et al., 2012; Tumanov et al., 2011). Transferring
either wild-type ILC3s cells (Sonnenberg et al., 2011) or Th22
cells (Basu et al., 2012) protects the mice from C. rodentium
infection. However, it is not clear whether the innate or adap-
tive RORgt+ lymphocytes are essential for protection against
infection.
ILCs represent a family of immune cells that have morpholog-
ical characteristics of lymphocytes but lack rearranged antigen
receptors. ILCs can produce an array of effector cytokines that
correspond to the cytokine profiles of the T helper cell subsets;
for example, IFN-g by group 1 ILCs (NK cells and ILC1) and
Th1 cells, IL-5 and IL-13 by group 2 ILCs (ILC2) and Th2 cells,
and IL-17 and IL-22 by ILC3s (including LTi, NCR+ ILC3, and
NCR ILC3) and Th17 and Th22 cells (Spits et al., 2013; Spits
and Cupedo, 2012; Spits and Di Santo, 2011). The current
dogma is that development and function of innate and adaptive
lymphoid cells are under the control of analogous transcription
factors. T-bet is involved in the development of NK, ILC1, and
Th1 cells (Fuchs et al., 2013; Gordon et al., 2012; Szabo et al.,
2000), and GATA3 is critical for the development of both ILC2
and Th2 cells (Furusawa et al., 2013; Hoyler et al., 2012; Klein
Wolterink et al., 2013; Mjo¨sberg et al., 2012; Moro et al., 2010;
Zheng and Flavell, 1997), whereas RORgt is required for the
development of both ILC3s and Th17 cells (Eberl et al., 2004;
Ivanov et al., 2006). STAT proteins are transcription factors
involved in the differentiation of T helper cells (O’Shea et al.,
2011). However, whether ILCs and T helper cells also share
STAT protein for their development and downstream cytokines
production is still unknown.Immunity 40, 25–39, January 16, 2014 ª2014 Elsevier Inc. 25
Figure 1. Sunitinib Impairs the Host Defense against Intestinal C. rodentium Infection
(A–C) 8-week-old wild-type mice were orally inoculated with 2 3 109 CFU of C. rodentium. Sunitinib (4 mg/kg, n = 6 or 40 mg/kg, n = 8) or control (n = 5) was
administered orally from day 0 to day 7, once daily.
(legend continued on next page)
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Differential STAT3 in ILCs and Adaptive Th CellsPrevious studies have shown that deletion of STAT3 in Th17
cells impairs their expression of RORgt and development (Ivanov
et al., 2006; Laurence et al., 2007; O’Shea et al., 2011; Veldhoen
et al., 2008; Yang et al., 2007, 2008; Zhou et al., 2007), but its role
in ILCs has not been examined yet. Because innate and adaptive
IL-17 producers share many transcriptional networks, it is ex-
pected that STAT3 also regulates RORgt expression in ILCs,
analogous to their adaptive counterparts. However, in contrast
to the STAT3-dependent development of Th17 and Th22 cells,
we revealed that STAT3 does not control RORgt expression in
ILCs, but rather directly regulates their production of IL-22 in
response to infection.
RESULTS
Sunitinib Impairs the Host Defense against Intestinal
C. rodentium Infection
To determine whether tyrosine kinase (including STAT3
pathway) inhibitor treatment increases the risk of gut infec-
tion, C. rodentium-infected mice were orally administered
Sunitinib at clinically relevant doses (Xin et al., 2009). After
C. rodentium infection, the mice with high-dose Sunitinib
(40 mg/kg) treatment developed severe diarrhea and rapidly
lost body weight, with nearly 50% mortality by 3 weeks; low-
dose Sunitinib (4 mg/kg)-treated mice also developed diarrhea
but lost less body weight, with few mortality by 3 weeks; how-
ever, neither weight loss nor death was observed in the control-
treated mice (Figures 1A and 1B). Sunitinib treatment also
resulted in increased bacterial titers in both feces and blood
at days 8 and 11 postinfection (Figure 1C). Compared with
control mice, the Sunitinib-treated mice exhibited severe
colonic pathology with severe disruption of the epithelial layer
and infiltration of inflammatory cells (Figure S1 available online).
Together, these data indicate that oral Sunitinib administra-
tion could increase morbidity and mortality after intestinal
C. rodentium infection.
Previous studies have shown that the Th17 and Th22 cell-
related cytokines (IL-17, IL-22, and IL-23) are important for
host defense against C. rodentium infection (Ishigame et al.,
2009; Zheng et al., 2008). To determine whether the increased
risk of intestinal infection by tyrosine kinase inhibition was
due to impaired host immune responses, the colonic cytokine
expression profile was examined at day 5 postinfection. In
contrast to Th1 and Th2 cell-related cytokines, the Th17 and
Th22 cell-related cytokines (IL-17 and IL-22) were upregulated
after infection but were suppressed by both in vivo and in vitro
Sunitinib treatment (Figures 1D and 1E and data not shown).
Although IL-23 from DCs or macrophages is a major inducer
for IL-22 production, Sunitinib had no effect on IL-23 production
(Figures 1D and 1E). Taken together, these data indicate
that Sunitinib impairs the host defense against intestinal(A and B) Body weight was measured at the indicated time points (A) and surviv
(C) Bacterial titers from blood and fecal homogenate cultures at indicated day p
(D) IL-22, IL-17, and IL23 levels from the colon culture supernatants of Sunitinib-
(E) The colons from untreated mice (n = 3) were removed at day 5 after infection
IL-17, and IL-23 levels were examined in the colon culture supernatants.
*p < 0.05, **p < 0.01, ***p < 0.001; ns, no significant difference (Student’s t test)
(mean ± SEM). See also Figure S1.C. rodentium infection. It raises the possibility that STAT3 might
contribute to IL-22-dependent protection.
STAT3 Signaling from RORgt+ Lymphocytes Controls
C. rodentium Infection
IL-17 and IL-22 are known to be regulated byRORgt (encoded by
Rorc) and are mainly produced by RORgt+ ILCs and T cells (Iva-
nov et al., 2006; Qiu et al., 2012). To determine whether Suniti-
nib’s adverse effect was due to STAT3 inhibition on ILC3s and
T cells,Stat3-floxedmicewere crossedwithRorc-cre transgenic
mice to achieve specific deletion of STAT3 in RORgt-expressing
cells (Rorc-cre-Stat3fl/fl). Because RORgt is transiently ex-
pressed at high levels at the double-positive stage of T cell devel-
opment, Rorc-cre-Stat3fl/fl mice lack STAT3 expression not only
by RORgt+ ILC3s, but also bymost ab T cells (Figures S2A–S2C).
We next tested whether STAT3 signaling is necessary for con-
trolling the C. rodentium infection. After infection, Rorc-cre-
Stat3fl/fl mice rapidly lost body weight and died around day 10,
whereas no weight loss or death was observed in their littermate
control wild-type (Stat3fl/fl) mice (Figures 2A and 2B) orRorc-cre-
Stat3fl/+ heterozygous mice (Figure S2D). To test whether the
increasedmorbidity andmortality were associated with bacterial
colitis, we checked bacterial titer and diarrhea status. Rorc-cre-
Stat3fl/fl mice had 10–100 times higher bacterial titers in the feces
compared to WT mice at days 5 and 8 postinfection (Figures 2C
and S2E). Rorc-cre-Stat3fl/fl mice also showed increased
bacterial titers in the blood, liver, and spleen (Figures 2D
and S2E), suggesting systemic dissemination of C. rodentium.
The Rorc-cre-Stat3fl/fl mice exhibited severe diarrhea, colonic
shortening, severe inflammation, and tissue injury in the colon
and severe disruption of the epithelial layer compared with WT
mice (Figures 2E, 2F, and S2F). Together, these data indicate
that STAT3 signaling in RORgt+ cells is essential for host defense
against a mucosal bacterial pathogen.
STAT3 Signaling from RORgt+ Lymphocytes Controls
Both IL-22 and IL-17 Production during C. rodentium
Infection
We have shown that tyrosine kinase (including STAT3 pathway)
inhibition suppressed both IL-22 and IL-17 expression after
infection, which are required for the protection against
C. rodentium infection (Ishigame et al., 2009; Ivanov et al.,
2009; Wang et al., 2010; Zheng et al., 2008). We also measured
IL-22 and IL-17 amounts in the colon of WT and Rorc-cre-
Stat3fl/fl mice early after C. rodentium infection. Compared to
WT mice, expression of IL-22 and IL-17 was significantly
reduced in the colon of Rorc-cre-Stat3fl/fl mice on day 5 postin-
fection (Figure 3A). RegIIIg and RegIIIb, two antimicrobial pro-
teins dependent on IL-22 (Pickert et al., 2009; Zheng et al.,
2008), were also reduced in the colon of Rorc-cre-Stat3fl/fl
mice after infection (Figure 3A). These results suggest thatal rates (B) are shown.
ostinfection in the mice in (A) and (B).
or control-treated mice at day 5 after infection (n = 5 each group).
and cultured with Sunitinib at indicated concentrations for 24 hr in vitro. IL-22,
; nd, nondetectable. Data are representative of two independent experiments
Immunity 40, 25–39, January 16, 2014 ª2014 Elsevier Inc. 27
Figure 2. STAT3 Signaling Is Essential for Control of Intestinal C. rodentium Infection
7-week-old Rorc-cre-Stat3fl/fl (n = 7) and their littermate wild-type Stat3fl/fl (n = 9) mice were orally inoculated with C. rodentium (2 3 109 CFU) and body weight
was measured at the indicated time points.
(A and B) Body weight change (A) and survival rates (B) are shown.
(C) Bacterial titers from fecal homogenate cultures at indicated day postinfection in the mice in (A) and (B).
(D) Bacterial titers from blood and spleen, liver homogenate cultures at indicated day postinfection are shown.
(E) Rorc-cre-Stat3fl/fl mice show colon shortening at day 8 postinfection.
(F) Rorc-cre-Stat3fl/fl mice show more inflammatory monocyte or neutrophil infiltration in the colon. LPLs were isolated from colon and gated in CD45+ cells.
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of three independent experiments (A–C;mean ± SEM) or two independent experiments
(D, E; mean ± SEM). See also Figure S2.
Immunity
Differential STAT3 in ILCs and Adaptive Th CellsSTAT3 signaling is essential for IL-22 and IL-17 production in the
gut after mucosal bacterial infection.
Exogenous IL-22 but Not IL-17 Rescues
STAT3-Deficient Mice during C. rodentium Infection
Because both IL-17 and IL-22 are controlled by STAT3 signaling,
we wondered whether administration of exogenous IL-17 or IL-28 Immunity 40, 25–39, January 16, 2014 ª2014 Elsevier Inc.22 is sufficient to rescue Rorc-cre-Stat3fl/fl mice from death by
C. rodentium infection. To address this question, IL-17A- and
IL-22-expressing plasmids were hydrodynamically injected into
Rorc-cre-Stat3fl/fl mice on the same day as C. rodentium infec-
tion. All of the Rorc-cre-Stat3fl/fl mice treated with IL-22 survived
after infection and lost weight only slightly, whereas vector
and IL-17-alone-treated mice rapidly lost body weight and
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Differential STAT3 in ILCs and Adaptive Th Cellssuccumbed to C. rodentium infection (Figures 3B and 3C).
Accordingly, IL-22-treated Rorc-cre-Stat3fl/fl mice had reduced
bacterial counts in their feces and blood compared to vector
and IL-17-alone-treated mice (Figure 3D). Collectively, these
data demonstrate that exogenous IL-22 but not IL-17 is able
to rescue Rorc-cre-Stat3fl/fl mice from a lethal C. rodentium
infection and that IL-22 is an essential and sufficient pathway
downstream of STAT3 signaling to protect mice against mucosal
bacterial pathogens.
STAT3 Signaling Is Required for Both Innate and
Adaptive IL-22 Production
Previous studies have shown thatC. rodentium infection induces
an early wave of IL-22 production by ILC3s and a second wave
by CD4+ T (Th22) cells (Basu et al., 2012; Qiu et al., 2012; Tuma-
nov et al., 2011). To test whether STAT3 controls innate or adap-
tive IL-22 production, we examined cytokine expression in the
intestinal lamina propria lymphocytes (LPLs) isolated from both
naive and infectedRorc-cre-Stat3fl/fl andwild-typemice by intra-
cellular cytokine staining. Consistent with the previous studies
(Basu et al., 2012; Qiu et al., 2012), CD3 innate LPLs were the
main IL-22 producers compared to CD3+ T cells in naive and in-
fected WT mice at an early stage of infection (day 4), although
there were more IL-22-producing T cells than ILCs at a later
stage of infection (day 8) in WT mice (Figure 3E). However,
Rorc-cre-Stat3fl/fl mice had severely decreased expression of
IL-22 by intestinal LPLs, regardless of CD3 innate cells or
CD3+ T cells (Figures 3E, S3A, and S3B). Moreover, Sunitinib
treatment also suppressed IL-22 production in innate LPLs
from wild-type mice (Figure S3E). In a similar manner as IL-22,
the IL-17 production was also significantly reduced in both
innate and adaptive lymphocytes (Figures S3C and S3D).
Because PMA and ionomycin are not physiological stimuli, the
LPLswere also stimulatedwith anti-CD3 and anti-CD28 tomimic
TCR signaling. Similar to PMA and ionomycin treatment, STAT3-
deficient T cells also showed little IL-22 and IL-17 production
after anti-CD3 and anti-CD28 stimulation (Figure S3F). Together,
our data indicate that STAT3 signaling is essential for IL-22 and
IL-17 expression in both ILC3s and T cells.
STAT3 Signaling and IL-22 from ILC3s but Not from
T Cells Are Essential for the Control of C. rodentium
Infection
Because STAT3 signaling regulates IL-22 expression in both
innate and adaptive lymphocytes, we wondered whether innate
or adaptive IL-22 is more important for the protection from
C. rodentium infection. To test whether the STAT3 signaling
from ILC3s is sufficient for the protection against C. rodentium
infection in the transient absence of T cells, CD4 mAb was
administered to infected Rorc-cre-Stat3fl/fl and WT mice to
deplete the CD4+ T cells. To avoid depletion of CD4+ LTi cells,
we used a low dose of CD4 mAb to transiently remove CD4+
T cells but not CD4+ ILC3s. As shown in Figure S4A, 90% of
peripheral CD4+ T cells were depleted, but there was no propor-
tional reduction of ILC3s in the lamina propria after multiple CD4
mAb injections. Because CD4+ T cells are required for host
adaptive immunity especially for antibody responses against
C. rodentium (Bry et al., 2006), depletion of CD4+ T cells provided
another model to study whether the innate immune response issufficient against this pathogen in the absence of adaptive
responses. Treatment with CD4 mAb resulted in reduction of
C. rodentium-specific IgG in WT mice and all of them died at
3 weeks after C. rodentium infection (Figures S4B, 4A, and
4B), which is the same as Rag1/ mice, suggesting that adap-
tive immunity is responsible for the late phase of protection.
Treatment of Rorc-cre-Stat3fl/fl mice with additional CD4 mAb
did not aggravate or ameliorate the C. rodentium infection
compared with rat IgG (control for CD4 mAb) treatment group.
All of the Rorc-cre-Stat3fl/fl mice with or without depletion of
CD4+ T cells still died on day 8 postinfection (Figures 4A–4C).
These data suggest that STAT3 signaling and IL-22 from CD4+
T cells are not essential for protecting mice in the early phase
of C. rodentium infection.
To further test whether STAT3 signaling in T cells is required for
the later T and B cell response and prevention of chronic infec-
tion, we rescued Rorc-cre-Stat3fl/fl mice by exogenous IL-22
and examined the antibody production. IL-22-rescued Rorc-
cre-Stat3fl/fl mice produced the same amount of C. rodentium-
specific IgGasdidWTmice (FigureS4C).Moreover, 60days after
first C. rodentium infection, IL-22-rescued Rorc-cre-Stat3fl/fl
mice were challenged with a high dose of C. rodentium again.
Interestingly, none of the IL-22-rescued Rorc-cre-Stat3fl/fl mice
showed diarrhea (data not shown) or weight loss (Figure S4D),
suggesting that IL-22-rescuedRorc-cre-Stat3fl/flmicedeveloped
normal protection. Together, these data demonstrate that STAT3
signaling fromCD4+Tcells is not essential for normal IgGproduc-
tion and protecting mice after C. rodentium infection.
To further test whether the STAT3 signaling from RORgt+ ILCs
is sufficient for the protection against C. rodentium infection, we
crossed the Stat3-floxed mice with Cd4-cre mice to generate
mice lacking STAT3 only in T cells (Cd4-cre-Stat3fl/fl) but not in
CD4+RORgt+ ILCs (Eberl and Littman, 2004) (data not shown).
Even after a high dose of C. rodentium infection, the Cd4-cre-
Stat3fl/fl mice did not lose body weight and all survived (Fig-
ure 4D). Furthermore, the fecal titers of C. rodentium were not
significant higher in Cd4-cre-Stat3fl/fl mice than in WT mice
5–11 days after infection (Figure 4E). Similar to the Rorc-cre-
Stat3fl/fl mice, Cd4-cre-Stat3fl/fl mice also lacked IL-22-produc-
ing CD4+ T cells in the gut (Figures 4F and 4G). However, the
IL-22-producing ILCs inCd4-cre-Stat3fl/fl micewere not reduced
compared with WT mice, which were different with Rorc-cre-
Stat3fl/fl mice (Figures 3E, 4F, and 4G). Furthermore, CD4 mAb
was also administered to Cd4-cre-Stat3fl/fl mice and Stat3fl/fl
mice. As shown in Figures S4E and S4F, both CD4 mAb-treated
Stat3fl/fl and Cd4-cre-Stat3fl/fl mice lost body weight and died
around day 20 postinfection, whereas untreated mice survived,
suggesting that CD4+ T cells are important for the protection
against C. rodentium infection but that STAT3 signaling from
T cells is not essential. Together, these data demonstrate
that STAT3 signaling and IL-22 from ILC3s, but not CD4+
T cells, are essential for protecting mice from death during
C. rodentium infection.
CD90hiCD45lo ILC3s Protect Rorc-cre-Stat3fl/fl Mice
during C. rodentium Infection
Because we have shown that STAT3 signaling from ILC3s but
not T cells is essential for the protection fromC. rodentium infec-
tion, we wondered whether adoptive transfer of ILC3s couldImmunity 40, 25–39, January 16, 2014 ª2014 Elsevier Inc. 29
Figure 3. IL-22, but Not IL-17, Is an Essential and Sufficient Pathway Downstream of STAT3 Signaling to Protect Mice against C. rodentium
Infection
(A) Rorc-cre-Stat3fl/fl and wild-type Stat3fl/fl littermate mice (n = 5 per group) were infected with 2 3 109 CFU of C. rodentium. The mRNA expression of IL-22,
IL-17A, IL-17F, and IL-22-dependent RegIIIg andRegIIIb antimicrobial proteins in the colon of naive or 5 days infectedmiceweremeasured by real-time PCR. *p <
0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of two independent experiments (mean ± SEM).
(legend continued on next page)
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Differential STAT3 in ILCs and Adaptive Th CellsrescueRorc-cre-Stat3fl/fl mice from infection. However, because
of extremely low number of ILC3s and limited Rorcgfp/+ mice, it
was difficult to get enough ILC3s. To find a better cell surface
marker to identify ILC3s, we screened a large panel of surface
markers and found that ILC3s could be strictly identified
by CD45 and CD90. As shown in Figure 5A, after gating with
CD45 and CD90, CD90+ LPLs from the large intestine and
small intestine of Rag1/ mice fell into three separate popula-
tions: CD90hiCD45lo, CD90loCD45int, and CD90loCD45hi. Most
of CD90hiCD45lo LPLs (96%) were RORgt+ ILC3s, and most of
CD90loCD45int LPLs (95%) were NK1.1RORgt ILCs, whereas
nearly three fourths of CD90loCD45hi LPLs were NK1.1+ NK
cells. Similar to Rag1/ mice, CD90+ LPLs from both large
intestine and small intestine of C57BL/6 WT mice fell into two
separate populations: CD90hiCD45lo and CD90loCD45hi. Most
of CD90hiCD45lo LPLs (94%) were RORgt+ ILC3s, whereas
CD90loCD45hi LPLs were CD3+ T cells and other RORgt ILCs
(Figure S5). These data suggest that CD90hiCD45lo LPLs are
specific cell surface markers for intestinal RORgt+ ILC3s.
Then we sorted CD90hiCD45lo ILC3s and transferred small
number of them into Rorc-cre-Stat3fl/fl mice with C. rodentium
infection. Compared with untreated Rorc-cre-Stat3fl/fl mice,
ILC3s-transferred Rorc-cre-Stat3fl/fl mice lost less body weight
and about one third of the mice survived and recovered from
the C. rodentium infection (Figures 5B and 5C). Accordingly,
ILC3s-transferred Rorc-cre-Stat3fl/fl mice exhibited reduced
bacterial counts in their feces and blood compared to untreated
mice (Figure 5D). Collectively, these data demonstrate that
CD90hiCD45lo ILC3s are sufficient to protect mice against
C. rodentium infection.
The Development of RORgt+ Th Cells, but Not RORgt+
ILC3s, Requires STAT3 Signaling
Because Rorc-cre-Stat3fl/fl mice showed reduced IL-22 in both
ILCs and T cells, we next determined how STAT3 regulates IL-
22 production. IL-22 is mainly produced in RORgt+ cells, and
RORgt directly regulates IL-22 production at the transcriptional
level. Previous studies have shown that STAT3 regulates the
development of RORgt+ Th17 cells (Ivanov et al., 2006; Laurence
et al., 2007; Yang et al., 2007). To determine whether STAT3
signaling is shared by both innate and adaptive colonic RORgt+
cells for their development, we examined the RORgt expression
in the intestinal LPLs isolated from Rorc-cre-Stat3fl/fl mice and
their littermate control wild-type mice. Consistent with Cd4-
cre-Stat3fl/fl mice (Figure S6A), both the percentage and number
of RORgt+ Th cells (CD3+CD4+RORgt+) in the colon were much
lower inRorc-cre-Stat3fl/fl mice comparedwith theWTmice (Fig-
ures 6A–6C and S6B). Unexpectedly, there were no differences
in the percentages and numbers of the total RORgt+ ILC3s (Fig-(B–D)Stat3fl/fl (n = 5) andRorc-cre-Stat3fl/fl micewere orally inoculatedwith 23 10
both IL-17 and IL-22- (n = 4) expressing plasmids were hydrodynamically injected
(B and C) Body weight changes (B) and survival rates (C) were monitored at indi
(D) CFU counts ofC. rodentium in the fecal pellets and blood on day 5 after infectio
SEM). *p < 0.05, ***p < 0.001; ns, no significant difference (Student’s t test); nd,
(E) STAT3 signaling is required for both innate and adaptive IL-22 production. IL-
staining followed by flow cytometry.Rorc-cre-Stat3fl/fl andwild-typeStat3fl/fl litterm
isolated from the colons of Stat3fl/fl or Rorc-cre-Stat3fl/fl mice at day 4 and day 8
ionomycin (750 ng/ml) for 4 hr and gated in Thy1+ lymphocytes. Naive mice were
See also Figure S3.ures 6D–6F), the subsets of ILC3s (LTi, NCR+ ILC3, and NCR
ILC3; Figures 6D andS6C), or other ILCs (ILC1, ILC2; Figure S6C)
between Rorc-cre-Stat3fl/fl and WT mice, suggesting that
STAT3 was required for RORgt expression in T cells but not
ILC3s or maintenance of ILC3s. Moreover, similar to naive
mice, there were no differences in percentages and total
numbers of the ILC3s after C. rodentium infection between
Rorc-cre-Stat3fl/fl and WT mice (Figures 6E and 6F). Taken
together, our data indicate that STAT3 signaling is essential for
the development of RORgt+ Th cells, but not ILC3s, and that
STAT3-controlled IL-22 production is not through regulating
RORgt expression in innate cells, which also suggests that
RORgt is not sufficient to induce IL-22 production in the absence
of STAT3 signaling.
STAT3Directly Binds to the Il22 Locus and Regulates IL-
22 Production
Previous studies have shown that IL-23 is an inducer of IL-22
(Zheng et al., 2008). IL-23 interacts with the IL-23 receptor
(IL-23R) and activates STAT3, which has multiple target genes,
such as Il23r, Rorc, and Ahr in T cells (Ghoreschi et al., 2010;
Ivanov et al., 2006; Veldhoen et al., 2008). RORgt and Ahr can
bind to the Il22 locus and directly promote IL-22 production
(Qiu et al., 2012). Because the expression of RORgt in ILCs
was not reduced in Rorc-cre-Stat3fl/fl mice, we began to explore
other pathways, such as IL-23R or Ahr, defects in which could
result in a defective response to IL-23 and subsequently reduced
expression of IL-22. To test this hypothesis, we first examined
the expression of these related genes in the colon of WT and
Rorc-cre-Stat3fl/fl mice before or early after C. rodentium infec-
tion. Unexpectedly, there were no significant reductions of
IL-23p19, p40, IL-23R, and Ahr in the Rorc-cre-Stat3fl/fl mice
compared with WT mice, and the expression of RORgt was
actually increased in the STAT3-deficient mice, probably as a
secondary response to the increased infection (Figure 7A).
Interestingly, IL-6 was increased in Rorc-cre-Stat3fl/fl mice after
infection, indicating increased inflammation. Even with higher
expression of RORgt, the IL-22 production was still impaired,
suggesting that the regulation of IL-22 production by STAT3
signaling may not be mediated through these related pathways.
To further study themechanism of how STAT3 regulates IL-22,
ILC3s were purified from both Rorcgfp/+ and Rorc-cre-Stat3fl/fl
Rorcgfp/+ mice by flow cytometric sorting and stimulated with
IL-23. Consistent with the previous results, STAT3 is required
for IL-22 production in ILC3s after IL-23 stimulation. However,
there were no significant differences in IL-23R, RORgt, and Ahr
between STAT3-deficient and WT ILC3s (Figure 7B). Together,
these data suggest that STAT3 regulation of IL-22 is not through
IL-23R, RORgt, or Ahr.9 CFU ofC. rodentium. 10 mg control vector (n = 5), IL-17- (n = 5), IL-22- (n = 5), or
intoRorc-cre-Stat3fl/fl mice through the tail vein 6 hr afterC. rodentium infection.
cated time points.
n are shown. Data are representative of two independent experiments (mean ±
nondetectable.
22 expression in CD3 and CD3+ cells were analyzed by intracellular cytokine
ate mice were infectedwith 23 109 CFU ofC. rodentium. Intestinal LPLswere
postinfection. Cells were stimulated with IL-23 (25 ng/ml), PMA (50 ng/ml), and
used as control. Data are representative of three independent experiments.
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Figure 4. STAT3 Signaling and IL-22 from RORgt+ ILCs, but Not T Cells, Are Essential for Protection from C. rodentium Infection
(A–C) Rorc-cre-Stat3fl/fl and wild-type Stat3fl/fl mice were infected with 5 3 106 CFU of C. rodentium and injected intraperitoneally with mAb GK1.5 or rat IgG
(50 mg per mouse each time) at day 5, 0, 5, 10, and 15 postinfection for depletion of CD4+ T cells (4 to 6 mice per group).
(A and B) Average body weight change (A) and survival rates (B) at the indicated time points are shown.
(legend continued on next page)
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Differential STAT3 in ILCs and Adaptive Th CellsSTAT3 is a transcription factor that directly regulates IL-17
production (Yang et al., 2011). Therefore, we wondered whether
STAT3 can also directly regulate IL-22 production at the tran-
scriptional level. By using an in silico approach, we found multi-
ple STAT3 binding sites at the promoter and intron 1 of the Il22
gene (Hutchins et al., 2012), suggesting that the Il22 locus may
be a direct target of STAT3 (Figure 7C). Indeed, by using EL4
lymphoma cells stably expressing the double flag peptide
(DTFC) and double flag-tagged STAT3C (DFTC-STAT3C), an
active form of STAT3 (Zhou et al., 2007), a chromatin immuno-
precipitation (ChIP) assay by anti-flag antibodies showed
enhanced recruitment of STAT3 to the Il22 locus in cell lines
stably expressing DFTC-STAT3C, suggesting that Il22 is a direct
target gene of STAT3 (Figure 7D). To further confirm binding of
STAT3 to the Il22 locus in primary cells, we sorted ILC3s from
the intestinal LPLs of Rag1/ mice. ChIP assay with anti-
STAT3 antibody also showed enhanced recruitment of STAT3
to the Il22 locus in ILC3s (Figure 7E). Together, these data sug-
gest that STAT3 could directly bind to the Il22 locus and promote
IL-22 production in RORgt+ cells.
DISCUSSION
IL-22-producing innate lymphoid cells were shown to control
the dissemination of commensal bacteria and prevent systemic
inflammation in naive mice, which correlates with chronic infec-
tious diseases in humans, particularly in patients undergoing
prolonged treatments that increase their risk for nosocomial
infections of bacterial origins (Sonnenberg et al., 2012). How-
ever, how IL-22 is regulated by various transcriptional factors
is not fully understood. Our results show that the production
of IL-22 in both innate and adaptive lymphoid cells is depen-
dent on STAT3, suggesting that STAT3 inhibition or deficiency
may not only increase the chance of pathogen infection in
the gut but also result in the disruption of normal gut
homeostasis.
Th22 cells are an important source of IL-22 for host protection
against low-doseC. rodentium infection (Basu et al., 2012). Here,
we carefully utilized a complementary collection of conditional
gene-deficient mice combined with T cell-specific depletion to
show that IL-22 from T cells is not necessary for conferring pro-
tection even after high doses of C. rodentium inoculation.
Although adoptive transfer of IL-22-producing T cells rescues
IL-22-deficient mice from lethal infection (Basu et al., 2012),
this suggests that additional IL-22-producing T cells can suffi-
ciently control infection but does not prove that Th22 cells are
essential for the infection. Consistently, exogenous IL-22 can
sufficiently rescue many different gene-deficient mice from(C) Bacterial titers from blood and fecal homogenate cultures at day 5 postinfec
(D and E) Cd4-cre-Stat3fl/fl (n = 6) and wild-type Stat3fl/fl (n = 6) mice were orally
(D) Body weight changes are shown at the indicated time points.
(E) Bacterial titers from fecal homogenate cultures at indicated day postinfection
(F and G) IL-22 expression in CD3 and CD3+ cells were analyzed by intracellula
Stat3fl/fl littermate mice were infected with 2 3 109 CFU of C. rodentium. LPLs w
IL-23 (25 ng/ml), PMA (50 ng/ml), and ionomycin (750 ng/ml) for 4 hr and gated
Thy1+ LPLs are shown (G). Each dot represents one individual mouse.
*p < 0.05, **p < 0.01, ***p < 0.001; ns, no significant difference (Student’s t test)
(mean ± SEM). See also Figure S4.C. rodentium infection (Ota et al., 2011; Qiu et al., 2012; Tumanov
et al., 2011; Zheng et al., 2008). Our data suggest that STAT3 and
IL-22 from ILCs, but not Th22 cells, are essential for protecting
the host in normal physiology state.
It is thought that the development and function of ILCs and Th
cells are under the control of corresponding transcription fac-
tors (Hoyler et al., 2012; Zhou, 2012). However, our data sug-
gest that the transcriptional regulation of ILC3s and Th17 and
Th22 cells is complex and may be distinct between innate and
adaptive lymphocytes. In contrast to the essential role of con-
trolling RORgt expression in T cells (Yang et al., 2007; Zhou
et al., 2007), STAT3 has little impact on the development of
RORgt+ ILC3s. This finding could explain the major differences
in ontogeny between RORgt+ Th cells and ILC3s. ILC3s first
appear as fetal LTi cells that are generated on E12.5 during
ontogeny in the liver, whereas RORgt+ Th17 and Th22 cells
are differentiated from naive CD4+ T cells after birth dependent
on the commensal microbiota (Eberl, 2012). Germ-free mice
mostly lack RORgt+ Th cells. Colonization of germ-free mice
with segmented filamentous bacterium is sufficient to induce
Th17 cells in the small intestine (Ivanov et al., 2009). In contrast,
the development of ILC3s is independent of gut flora, although
there are debates about the influence of symbiotic microbiota
on some subsets or function of ILC3s (Sanos et al., 2009;
Satoh-Takayama et al., 2008; Sawa et al., 2011; Sonnenberg
and Artis, 2012). Our data suggest that STAT3 signaling is
necessary for the host to sense the environmental microbiota
and subsequently generate RORgt+ Th cells but not to ‘‘pro-
gram’’ the expression of RORgt in microbiota-independent
ILCs. Thus, the mechanisms underlying the differential regula-
tion RORgt expression by STAT3 in ILCs and T cells remain to
be defined.
STAT3 is one of the downstream adaptors of IL-23R signaling
and regulates the expression of RORgt, Ahr, and IL-23R in T cells
(Ghoreschi et al., 2010; Ivanov et al., 2006; Veldhoen et al., 2008).
Presumably, IL-23 activates the STAT3 signaling, which induces
RORgt, Ahr, and IL-23R expression, and then subsequent induc-
tion of RORgt and Ahr regulates IL-22 production. However, our
data show that the STAT3 deficiency in ILC3s has minimal
impact on the expression of RORgt, Ahr, and IL-23R, but rather
activated STAT3 directly binds to the Il22 locus to regulate IL-22
transcription, suggesting that the expression of RORgt in ILC3s
is not sufficient to promote IL-22 production in the absence of
STAT3. Both RORgt and STAT3 are required for IL-22 produc-
tion, and RORgt regulating IL-22 production is dependent on
STAT3 signaling in ILCs, raising the questions of whether RORgt
controls STAT3 signaling and how STAT3 and RORgt cooperate
on regulating IL-22 production in ILCs.tion. Each dot represents one individual mouse.
infected with 2 3 109 CFU of C. rodentium.
in the mice in (D).
r cytokine staining followed by flow cytometry. Cd4-cre-Stat3fl/fl and wild-type
ere isolated from the colons at day 8 postinfection. Cells were stimulated with
in Thy1+ lymphocytes. Percentage of IL-22+CD3 and IL-22+CD3+ cells in the
; nd, nondetectable. Data are representative of two independent experiments
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Figure 5. CD90hiCD45lo ILC3s Protect Rorc-cre-Stat3fl/fl Mice from C. rodentium Infection
(A) Intestinal CD90hiCD45lo LPLs are RORgt+ ILCs. LPLs were isolated from both the large intestine and small intestine of Rag1/mice and gated by CD45 and
CD90 expression. Three separate populations, CD90hiCD45lo, CD90loCD45int, and CD90loCD45hi were further analyzed with the expression of NK1.1 and RORgt.
Data are representative of two independent experiments.
(legend continued on next page)
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Figure 6. The Development of RORgt+ T Helper Cells but Not RORgt+ ILCs Is Dependent on STAT3 Signaling
Colonic LPLs were isolated from Stat3fl/fl and Rorc-cre-Stat3fl/fl littermate mice before or 5 days after C. rodentium infection.
(A and D) RORgt and CD4 expression were analyzed in colonic LPLs from naive mice by flow cytometry after gating on Thy1+CD3+ adaptive lymphocytes and
Thy1+CD3 innate lymphoid cells.
(B and C) Percentage of RORgt+ cells in the CD4+CD3+ T cell population as well as the absolute numbers of RORgt+CD4+ T cells in the colons of naive and
C. rodentium-infected Stat3fl/fl and Rorc-cre-Stat3fl/fl mice are shown.
(E and F) Percentage of RORgt+ cells in the CD3Thy1+ ILCs population as well as the absolute numbers of RORgt+ ILCs in the colons of naive and C. rodentium-
infected Stat3fl/fl and Rorc-cre-Stat3fl/fl mice are shown.
**p < 0.01, ***p < 0.001; ns, no significant difference (Student’s t test). Data are representative of three independent experiments (mean ± SEM). Each dot
represents one individual mouse (B, C, E, F). See also Figure S6.
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Differential STAT3 in ILCs and Adaptive Th CellsTogether, our studies have demonstrated several important
findings. (1) In contrast to the essential role of controlling the
expression of RORgt in T cells, STAT3 has little impact on
the development of RORgt+ ILC3s, but rather directly regulates
the function of innate RORgt+ ILC3s, which is essential for
gut immunity. (2) Although STAT3 regulates the function of
both innate and adaptive RORgt+ cells, our data suggest
that STAT3 signaling and IL-22 from innate RORgt+ ILC3s
but not from adaptive T cells are essential in the response to(B–D) Rag1/mice were infected with 23 109 CFU of C. rodentium and CD90hiC
postinfection. Sorted ILC3s were stimulated with IL-23 (25 ng/ml) for 1 hr, then
recipients at day 0 and day 3 after inoculation with 53 106 CFU ofC. rodentium. U
(B and C) Body weight changes (B) and survival rates (C) were monitored at indi
(D) CFU counts of C. rodentium in the fecal pellets and blood on day 5 after infec
mice per group (mean ± SEM). ***p < 0.001 (Student’s t test).
See also Figure S5.acute mucosal bacterial infections. (3) Previous studies have
shown that STAT3 signaling controls IL-22 production by
T cells through regulating RORgt expression. Our data show
that STAT3 can directly control IL-22 production. (4) STAT3
inhibition in a major antitumor therapy also impairs the
host protection from intestinal bacterial infection. Exogenous
IL-22 administration may be beneficial for reducing side
effects in the cancer patients undergoing STAT3 inhibitor
treatment.D45lo ILC3s were sorted from both the colon and small intestine LPLs at day 1
transferred by i.v. injection (2 3 105 cells per mouse) into Rorc-cre-Stat3fl/fl
ntreated Rorc-cre-Stat3fl/fl and wild-type Stat3fl/fl littermate mice were controls.
cated time points.
tion are shown. Data are pooled from two independent experiments with 9–11
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Figure 7. STAT3 Directly Binds to the Il22 Locus and Regulates IL-22 Production
(A)Rorc-cre-Stat3fl/fl and Stat3fl/fl littermate mice (n = 5 per group) were infected with 23 109 CFU ofC. rodentium. ThemRNA expression of IL-23 p19, IL-23 p40,
IL-23R, IL-6, RORgt, and Ahr in the colon were measured by real-time PCR before and 5 days after infection. Data are representative of two independent
experiments (mean ± SEM).
(B) RORgt+ ILCs were purified by flow cytometric sorting from colonic LPLs of Rorc-cre-Stat3fl/flRorcgfp/+ and Rorcgfp/+ mice and stimulated with or without IL-23
(25 ng/ml) for 1 hr. The mRNA expression of IL-22, IL-23R, RORgt, and Ahr were measured by real-time PCR. Data are representative of two independent
experiments (mean ± SEM).
(C) STAT3 binding sites at the Il22 locus are shown.
(legend continued on next page)
Immunity
Differential STAT3 in ILCs and Adaptive Th Cells
36 Immunity 40, 25–39, January 16, 2014 ª2014 Elsevier Inc.
Immunity
Differential STAT3 in ILCs and Adaptive Th CellsEXPERIMENTAL PROCEDURES
Mice
C57BL/6 and Rag1/ mice were purchased from Harland Teklad. Cd4-cre
(Lee et al., 2001) mice were purchased from Taconic. Rorcgfp/+ (Eberl et al.,
2004) mice were purchased from The Jackson Lab. Rorc-cre-Stat3fl/fl, Rorc-
cre-Stat3fl/+, and Cd4-cre-Stat3fl/fl mice were generated by crossing Stat3-
floxed mice (Takeda et al., 1998) with Rorc-cre (Eberl and Littman, 2004)
and Cd4-cre transgenic mice, respectively. Rorc-cre-Stat3fl/flRorcgfp/+ mice
were generated by crossing Rorc-cre-Stat3fl/fl mice with Rorcgfp/+ mice. All
mice are on C57BL/6 background. Animal care and use were in accordance
with institutional and National Institutes of Health guidelines and all studies
were approved by the Animal Care and Use Committee of the University of
Chicago and Northwestern University.
Infection with C. rodentium and Treatment
Mice were orally gavaged with C. rodentium strain DBS100 (ATCC 51459;
American Type Culture Collection) and body weight, survival, colony-forming
units (CFUs) counts, and tissue histology were assessed as previously
described (Tumanov et al., 2011; Wang et al., 2010). Colon culture was done
as previously described (Zheng et al., 2008). Where indicated, Sunitinib
(SU11248; SUTENT) or control was gavaged orally, once a day, at doses of
4 or 40mg/kg body weight after infection. Where indicated, mice were injected
intraperitoneally with mouse IL-22-Ig fusion protein on 0, 2, and 4 days after
C. rodentium infection at a dose of 50 mg per mouse each time. Control groups
received isotype control immunoglobulin. For depletion of CD4+ T lympho-
cytes, mice were injected intraperitoneally with mAb GK1.5 or rat IgG on 5,
0, 5, 10, and 15 days after C. rodentium infection at a dose of 50 mg per mouse
each time. Where indicated, IL-17- and IL-22-expressing plasmids were intro-
duced into mice by a hydrodynamic tail vein injection-based gene transfer
technique (Tumanov et al., 2011).
Isolation of Intestinal LPLs
The isolation of intestinal lamina propria cells was done as previously
described (Wang et al., 2010). In brief, mice were killed and colons were
removed and placed in ice-cold PBS. The intestines were cut open longitudi-
nally, thoroughly washed in ice-cold PBS, and cut into 1.5 cm pieces. Intes-
tines were incubated with shaking in RPMI 1640 (Invitrogen) containing 3%
FBS, 1 mM DTT, 5 mM EDTA, and 10 mM HEPES at 37C for 30 min. After
washing with RPMI 1640 containing 2 mM EDTA, the tissues were then di-
gested in RPMI 1640 containing 0.05% DNase I (Sigma) and Liberase (Roche)
(0.1 mg/ml) at 37C for 30 min with slow rotation. The digested tissues were
homogenized by vigorous shaking and passed through 100 mm cell strainer.
Mononuclear cells were then harvested from the interphase of an 80% and
40%Percoll gradient after a spin at 2,500 rpm for 20 min at room temperature.
Flow Cytometry, Antibodies, and ELISA
Antibodies against CD3, CD4, CD8, CD45, CD90, NKp46, Gr-1, CD11b,
KLRG1, TCRb, NK1.1, andStreptavidin-APCwere purchased fromBioLegend.
Antibodies against RORgt and IL-17 were purchased from eBioscience. Anti-
bodies against STAT3 and rabbit IgGwere purchased fromCell Signaling Tech-
nology. Anti-IL-22 antibody was a gift from Genentech. For nuclear staining,
cells were fixed and permeabilized with a Transcription Factor Staining Buffer
Set (eBioscience). For cytokine production, cells were stimulated ex vivo by IL-
23 (25 ng/ml, R&D), PMA (50 ng/ml, Sigma) and ionomycin (750 ng/ml, Calbio-
chem), or anti-CD3 (plate coated, 1 mg/ml) and anti-CD28 (2 mg/ml) for 4 hr and
Brefeldin A (10 mg/ml, eBioscience) was added 2 hr before cells were harvested
for analysis. IC Fixation Buffer and Permeabilization Buffer were used accord-(D) STAT3 binding at the Il22 locus in EL4 cell lines stably expressing either flag pe
assay. The anti-flag antibody immunoprecipitates were analyzed by real-time P
DFTC-empty EL4 cells. Ltbr and Il17 loci were used as negative and positive co
pendent experiments (mean ± SEM of triplicate samples of real-time PCR).
(E) CD90hiCD45lo ILC3s were sorted from Rag1/ mice and stimulated with IL-2
enrichment of STAT3 at the Il22 locus in primary ILC3s. Ltbr loci lacking STAT3
independent experiments (mean ± SEM of quadruplicate samples of real-time P
*p < 0.05, **p < 0.01, ***p < 0.001; ns, no significant difference (Student’s t test).ing to the manufacturer’s instructions (eBioscience) for intracellular cytokine
staining. Flow cytometry analysis was performed on FACSCanto (BD Biosci-
ences) instruments and analyzed with FlowJo software (Tree Star). IL-22
(R&D Systems), IL-17, and IL-23 (eBioscience) in supernatants weremeasured
by ELISA according to the manufacturer’s recommendations.
Quantitative Real-Time RT-PCR
RNA from tissues was isolatedwith Trizol reagent (Invitrogen) and reverse tran-
scribed with AMV Reverse Transcriptase (Promega). RNA from sorted cells
was isolated with the RNeasy Micro Kit (QIAGEN) and was reverse transcribed
with Seniscript Reverse Transcription Kit (QIAGEN). Real-time RT-PCR was
performed with SSoFast EvaGreen supermix (Bio-Rad) and different primer
sets (Table S1) on StepOne Plus (Applied Biosystems). Samples were normal-
ized to HPRT and reported according to the 2DDCT method.
Adoptive Transfer Experiments
Rag1/ mice were infected with C. rodentium. CD90hiCD45lo ILC3s were
sorted from both the colon and small intestine LPLs on a FACS Aria III instru-
ment (BD Bioscience) at day 1 postinfection. Sorted ILC3s were stimulated
with IL-23 (25 ng/ml) for 1 hr, thenwere transferred by i.v. injection (23 105 cells
per mouse) into recipients inoculated with C. rodentium at day 0 and day 3.
Chromatin Immunoprecipitation
ChIP assays with EL4 cells were performed as previously described (Qiu et al.,
2012). In brief, 5 3 107 EL4 cells were first fixed in 1% formaldehyde in RPMI
1640media for 10min at room temperature. The reaction was then stopped by
adding glycine solution. Fixed cells were washed with PBS and resuspended
in lysis buffer. Chromatin was sheared by sonication on ice, and the insoluble
fraction was removed by centrifugation. The lysate was precleared with Pro-
tein A beads (Santa Cruz Biotechnology) and then incubated with anti-Flag
beads (Sigma) at 4C for 5 hr. After washing, precipitated chromatin fragments
were eluted with flag peptide (Sigma). The samples were then reverse cross-
linked at 65Cby adding Tris-EDTAwith 1%SDS. After proteinase K digestion,
DNA was extracted with Phenol-Chloroform and precipitated for quantitative
real-time PCR analyses by specific primers. CD90hiCD45lo ILC3s were sorted
from Rag1/ mice and ChIP assays were performed with anti-STAT3 rabbit
mAb (D3Z2G) or rabbit IgG (Cell Signaling Technology). MegnaChIP protein
A magnetic beads (Millipore) were used to isolate immune complexes. Cross-
links were reversed by heating at 65C and proteinase K treatment. DNA was
purified with Qiaquick PCR purification kit (QIAGEN).
Statistical Methods
Statistical analysis was performed by two-tailed Student’s t test on GraphPad
Prism 5.0 program. Data from such experiments are presented as mean
values ± SEM; p < 0.05 was considered significant. For survival curves, statis-
tics were done with the log rank (Mantel-Cox) test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.10.021.
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